|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$179,961
|
N/A
|
(NCI)
|
|
Novel Mechanism for Myc-Induced Apoptosis
|
1F31CA165728-01A1
|
$26,592
|
$26,592
|
Adams, Clare
|
VANDERBILT UNIVERSITY MED CTR
|
|
microRNA-155 and Lymphoma
|
5R01CA138747-03
|
$298,894
|
$298,894
|
Aguiar, Ricardo
|
UNIV OF TX HSC, SA
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
$2,164
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,451,134
|
$145,113
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$129,458
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$3,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$5,754
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$158,153
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-43S1
|
$127,557
|
$7,653
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-43
|
$2,516,654
|
$150,999
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Signal Transduction in T Lymphocyte Activation
|
5R01CA035299-29
|
$306,129
|
$153,065
|
Altman, Amnon
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Convergence of CREB and MYC Pathways in Oncogenesis.
|
1K99CA157954-01A1
|
$147,150
|
$103,005
|
Amelio, Antonio
|
SCRIPPS FLORIDA
|
|
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
|
5R01CA151533-02
|
$327,850
|
$327,850
|
AMIN, HESHAM
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Mechanisms of GVHD
|
5P01CA142106-09
|
$1,867,308
|
$672,231
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
5K24CA128953-05
|
$171,205
|
$34,241
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIASC010378
|
$441,016
|
$220,508
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIASC010379
|
$220,508
|
$88,203
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
2P01CA018029-37A1
|
$4,225,448
|
$380,290
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Cancer Cytogenetics
|
ZIDBC010694
|
$580,330
|
$58,033
|
Arthur, Diane
|
CCR (NCI)
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
$3,235
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
$14,765
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$3,549
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mid-Region AIDS and Cancer Specimen Resource Consortium
|
5U01CA066531-17
|
$692,356
|
$346,178
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
Molecular Basis of Action of the Putative Oncogene BCL-6
|
5R01CA071540-15
|
$301,671
|
$301,671
|
BARDWELL, VIVIAN
|
UNIVERSITY OF MINNESOTA
|
|
Kaiser NHL - Nested Case-Control Study
|
ZIA CP010121-02113
|
$8
|
$8
|
Baris, Dalsu
|
DCEG (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
$17,466
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Clinical and Molecular Studies of Malignant Brain Tumors
|
2K24CA125440-06
|
$185,972
|
$46,493
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-06A1
|
$7,500
|
$7,500
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIABC010620
|
$90,730
|
$22,682
|
Bates, Susan
|
CCR (NCI)
|
|
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
|
ZIABC010621
|
$589,742
|
$353,845
|
Bates, Susan
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-23S1
|
$75,000
|
$750
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-23
|
$1,454,512
|
$14,545
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Development of cambinol analogues as antilymphoma agents
|
5R01CA129132-05
|
$354,244
|
$354,244
|
BEDALOV, ANTONIO
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Oncogenes and oncogenic microRNAs in chicken tumors
|
5R01CA124596-05
|
$324,400
|
$324,400
|
Beemon, Karen
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting B-cell lymphoma with Leukothera
|
1R41CA173900-01
|
$202,601
|
$202,601
|
Belinka, Benjamin
|
ACTINOBAC BIOMED, INC.
|
|
ECOG Clinical Trials
|
5U10CA017145-37
|
$415,756
|
$4,158
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$223,292
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$1,131
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-24
|
$355,104
|
$3,551
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Cancer Risk in Pediatric-Onset Rheumatic Disease
|
5R03CA149970-02
|
$43,351
|
$21,676
|
Bernatsky, Sasha
|
MCGILL UNIVERSITY HEALTH CTR RES INST
|
|
Pediatric Oncology Research Training Program
|
2T32CA009351-34
|
$235,116
|
$11,756
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-04
|
$137,885
|
$6,894
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-14
|
$550,042
|
$165,013
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients
|
5R01CA122645-05
|
$308,376
|
$308,376
|
BERNSTEIN, STEVEN
|
UNIVERSITY OF ROCHESTER
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$5,711
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$8,118
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $119,470,587
|